Related Experiment Video
Updated: Aug 18, 2026

Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels
Published on: May 26, 2023
Status of femoral closure devices
Timothy A Sanborn1, Ted Feldman
1Division of Cardiology, Evanston Northwestern Healthcare, Evanston, IL 60201, USA. tsanborn@enh.org
Insights
Vascular closure devices shorten bleeding time and improve patient mobility after cardiac procedures. Newer devices offer enhanced safety and ease of use, potentially reducing complications.
Area of Science:
- Cardiovascular Interventions
- Medical Device Technology
Background:
- Conventional compression methods after cardiac catheterization can be uncomfortable and delay ambulation.
- Vascular closure devices offer an alternative to manual or mechanical compression.
Purpose of the Study:
- To evaluate the efficacy and safety of vascular closure devices compared to conventional compression.
- To assess the impact of newer generation devices on patient outcomes and practice adoption.
Main Methods:
- Review of studies comparing closure devices with manual/mechanical compression.
- Analysis of complication rates and ambulation times.
- Consideration of device improvements and cost-effectiveness.
Main Results:
- Closure devices shorten hemostasis time and allow earlier ambulation.
- Reduced vascular complications observed, particularly with glycoprotein IIb/IIIa inhibitors.
- Predeployment femoral angiogram is standard practice for device use.
Conclusions:
- Vascular closure devices provide benefits in hemostasis and patient mobility.
- Ongoing device development aims for improved safety and user-friendliness.
- Widespread adoption depends on reliable hemostasis, simplicity, and cost-effectiveness.
Abstract:
Both sealing and suturing closure devices have been shown to shorten hemostasis time, reduce the discomfort of manual or mechanical compression, and allow for earlier ambulation after cardiac catheterization and percutaneous coronary interventions without increasing vascular complications compared with conventional compression techniques. Several studies now report a reduction in vascular complications for percutaneous coronary intervention patients treated with closure devices compared with manual compression with pronounced benefit seen in patients receiving glycoprotein IIb/IIIa receptor inhibitors. Adoption of a simple predeployment femoral angiogram is now standard practice for use of a closure device. In an attempt to develop devices that are safer and more "user friendly," considerable modifications and improvements have been made in newer generation devices. Ultimately, the acceptance of femoral closure devices will depend on which device provides a simple approach with reliable hemostasis and a cost that can justify their incorporation into routine practice.
More Related Videos
10:52Closure of a Patent Foramen Ovale (PFO): An Intervention Sequence
Published on: December 23, 2022
20:33A Case Series of Successful Abdominal Closure Utilizing a Novel Technique Combining a Mechanical Closure System with a Biologic Xenograft that Accelerates Wound Healing
Published on: July 4, 2019